Are post-docetaxel treatments effective in patients with castration-resistant prostate cancer and performance of 2? A meta-analysis of published trials

Are post-docetaxel treatments effective in patients with castration-resistant prostate cancer and performance of 2? A meta-analysis of published trials

Prostate Cancer and Prostatic Diseases advance online publication, July 30 2013.
doi:10.1038/pcan.2013.20

Authors: R Iacovelli, A Altavilla, G Procopio, S Bracarda, M Santoni, S Cascinu
& E Cortesi

Source: Prostate Cancer and Prostatic Diseases - July 30, 2013 Category: Urology & Nephrology Authors: R IacovelliA AltavillaG ProcopioS BracardaM SantoniS CascinuE Cortesi Tags: castration-resistant prostate cancer second line abiraterone acetate cabazitaxel enzalutamide performance status Source Type: research